Register for our free email digests:
Latest From Chiasma Inc.
This week’s roundup includes CEO appointments by Smart Matrix and IRX Therapeutics, with various senior level appointments by companies including Therachon, Mission Therapeutics and bluebird bio.
Office of Prescription Drug Promotion seemed to expand its focus in issuing 11 letters last year.
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
With a near-term launch of Mycapssa unlikely, Chiasma cuts its commercial staff while it evaluates how to respond to an April complete response letter.
- Large Molecule
- Drug Delivery
- Therapeutic Areas
- Metabolic Disorders
- Musculoskeletal & Connective Tissue Disorders
- Chiasma (Israel) Ltd.
- North America
- Parent & Subsidiaries
- Chiasma Inc.
- Senior Management
Mark J Fitzpatrick, Pres. & CEO
Asi Haviv, DMD, VP, Clin. Dev.
Steven Vickers, VP, Sales
- Contact Info
Phone: (972)(866) 637-9703
60 Wells Ave.
Newton, MA 02459
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.